UPLOAD Filing
CytoDyn Inc.
Date: July 31, 2025 · CIK: 0001175680 · Accession: 0000000000-25-008087
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288970
Letter
Re: CytoDyn Inc. Registration Statement on Form S-3 Filed July 25, 2025 File No. 333-288970 Dear Robert Hoffman:
July 31, 2025
Robert Hoffman Chief Financial Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, WA 98660
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Mary Ann Frantz
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 31, 2025 Robert Hoffman Chief Financial Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, WA 98660 Re: CytoDyn Inc. Registration Statement on Form S-3 Filed July 25, 2025 File No. 333-288970 Dear Robert Hoffman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary Ann Frantz </TEXT> </DOCUMENT>